Today's health news spans breakthrough imaging technologies, emerging treatments for complex diseases, and new insights into disease associations, from CAR T-cell therapy expanding to skin conditions to machine learning predicting epilepsy and depression onset.

Advanced machine learning identifies shared risk factors between epilepsy and depression, enabling better prediction of disease onset in patients with these neurological and psychiatric conditions.

CAR T-cell therapy is poised for regulatory approval to treat autoimmune skin diseases, potentially expanding treatment options across dermatology following anticipated authorization this year.

A new 5D MRI technique significantly reduces scan time for heart imaging in congenital heart disease patients, providing faster and more simplified whole-heart evaluation using gadolinium enhancement.

Traumatic brain injury shows bidirectional associations with stroke, dementia, epilepsy, and Parkinson's disease, meaning TBI increases risk for these conditions and vice versa, according to retrospective study findings.

Nearly 10% of primary biliary cholangitis patients develop chronic kidney disease, which substantially increases mortality risk and requires closer clinical monitoring.

Merkel cell carcinoma patients experience higher mortality rates, more hospitalizations, and greater comorbidity burden compared to matched controls and other cancer cohorts.

Cognitive rehabilitation therapy helps long-COVID patients manage brain fog by establishing achievable goals such as reading for 20 minutes or completing short work tasks.

Topical steroid withdrawal remains controversial in eczema treatment, with experts emphasizing compassionate care and patient autonomy in treatment decisions regarding medication cessation.